A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
Note that you will be prompted to log in or register an account
Accession Number
HLB00300404a
Study Type
Epidemiology Study
Collection Type
Open BioLINCC Study
See bottom of this webpage for request information
Study Period
June 1995 - March 2003
NHLBI Division
DLD
Dataset(s) Last Updated
July 17, 2020
Clinical Trial URLs
https://clinicaltrials.gov/ct/show/NCT00005276
Primary Publication URLs
N/A
Consent
Commercial Use Data Restrictions No
Data Restrictions Based On Area Of Research No
Commercial Use Specimen Restrictions No
Non-Genetic Use Specimen Restrictions Based On Area Of Use Yes
Genetic Use Of Specimens Allowed? Yes
Genetic Use Area Of Research Restrictions Yes
Specific Consent Restrictions
Biospecimen research is restricted to studies related to sarcoidosis. Use of data is unrestricted.
Objectives
To determine the etiology of sarcoidosis by establishing a case control, multi-center study. In addition to etiology, this study also sought to examine socioeconomic variables and the clinical course of patients with sarcoidosis, including quality of life.
Background
Sarcoidosis is a chronic granulomatous disorder of unknown cause that is characterized by activation of T-lymphocytes and macrophages. For many years sarcoidosis was presumed to be an atypical manifestation of tuberculosis because of the similarity between the inflammatory responses of the two diseases. However, as culture techniques became more widely employed to diagnose tuberculosis and it became less common, it became clear that sarcoidosis was not simply a variation of tuberculosis. Data on the etiology of sarcoidosis have come from diverse sources: in clinical investigations, alveolitis has been found to precede granulomatous inflammation; in case control studies, familial aggregation has been identified; and in case reports, recurrence of granulomatous inflammation has been observed after lung transplantation. The cause may not prove to be a single, known exposure. Interactions of exposures with genetic dispositions could have important implications for our understanding of immune responses as well as the pathogenesis of sarcoidosis.
Participants
736 patients with sarcoidosis enrolled within 6 months of diagnosis from 10 clinical centers in the U.S. Using the ACCESS sarcoidosis assessment system, organ involvement was determined for the whole group and for subgroups differentiated by sex, race, and age (<40 or 40 and older). Cases were matched with a control, and there was a two-year follow-up on cases. The ACCESS group proposed an instrument fo defining organ involvement in sarcoidosis. Biological specimens included DNA, plasma, and bronchoalveolar lavage samples were obtained. The data set includes 718 cases, 686 controls, and two-year follow-up data on 241 cases.
Conclusions
The initial presentation of sarcoidosis is related to sex, race and age, and it tends to remain stable over two years in the majority of patients. The etiology is probably multifactoral with both genetic and environmental factors contributing.
Specimen Details
The PBMC for this study are pelleted and suspended in guanidinium-based solution and are nonviable.
Additional Details
Cases: 718
Controls: 686
| Case | Control | Total Subjects |
---|---|---|---|
18-29 | 80 | 75 | 155 |
30-39 | 247 | 222 | 469 |
40-49 | 214 | 224 | 438 |
50-59 | 129 | 118 | 247 |
>=60 | 48 | 47 | 95 |
| Case | Control | Total Subjects |
---|---|---|---|
Male | 261 | 243 | 504 |
Female | 457 | 443 | 900 |
| Case | Control | Total Subjects |
---|---|---|---|
White | 393 | 380 | 773 |
Black or African American | 325 | 306 | 631 |
Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3 of the BioLINCC handbook describes the components of the review process
10/31/2024
Plasma | DNA | PBMC | Bronchoalveolar Lavage (BAL) | Total Vials |
---|---|---|---|---|
14,488 | 29,389 | 1,394 | 633 | 45,904 |
10/31/2024
Plasma | |
---|---|
Total number of subjects | Average volume (mL) per subject |
1,424 | 11.87 |
DNA | |
---|---|
Total number of subjects | Average mass (mg) per subject |
1,426 | 20.61 |
PBMC | |
---|---|
Total number of subjects | Average volume (mL) per subject |
1,218 | 1.14 |
Bronchoalveolar Lavage (BAL) | |
---|---|
Total number of subjects | Average volume (mL) per subject |
73 | 8.67 |
Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.
Resources Available
Specimens and Study DatasetsMaterials Available
- Bronchial Lavage
- DNA
- Peripheral Blood Mononuclear Cells
- Plasma
- More Details
Study Documents
Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.